跳到正文
KOL Pulse AI· @KolPulseAI · X·· 2 天前评分70

SANO

正文 · 原文

"No significant OS difference does not establish equivalence!!!!" @Dr_ElvinaA

SANO 5-yr #ESMO26 LBA78, oesophageal cancer, surveillance vs surgery after cCR:
OS 50% vs 54%, HR 1.17 (NS)
Distant mets 46% vs 29%, P<.01

Reactions:
https://hubs.ly/Q04C9xBh0
@ErasmusMC @SuyogCancer

106 浏览 · 2 赞 · 1 转发 · 0 回复

会议摘要
LBA78按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上

Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: Long-term results of a cluster-randomised controlled trial (SANO)

https://esmocongress.esmo.org

来源:KOL Pulse AI · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org